Students in India are making cooking measurements more accessible with these spice cubes!
Students in India are making cooking measurements more accessible with these spice cubes!
(Bloomberg) -- Technology shares led U.S. stocks lower before earnings and an influx of bond supply that loom as speedbumps to a roaring rally.The communication services and information technology sectors pushed the S&P 500 into negative territory in the wake of a third straight week of gains for the benchmark index. In Europe, retailers and travel companies led declines on the Stoxx Europe 600 Index.The yield on 10-year Treasuries ticked higher before a round of auctions that will be widely watched for their potential to extend the rate surge that’s shaken stocks to commodities to emerging markets this year. The U.S. sells three-, 10- and 30-year Treasuries at the start of the week.“While the outlook for stocks is positive, the scenario where we get materially higher prices is getting pretty ‘perfect,’ and while it can happen, it usually doesn’t,” Tom Essaye, the founder of “The Sevens Report” newsletter, wrote to clients.While the U.S. recovery is accelerating, parts of Europe and South America are beset by rising Covid-19 cases and troubled vaccination rollouts. The rotation toward cyclical and small-cap stocks appears to have stalled as well, prompting worry about the strength of the U.S. economic comeback at the start of earnings season.“The breakdown of small caps and cyclicals is a potential early warning sign that the actual reopening of the economy will be more difficult than dreaming about it,” Morgan Stanley strategist Mike Wilson wrote in a client note.At the same time, massive government spending and central-bank stimulus could stoke excessive inflation. In an interview aired Sunday with CBS’s 60 Minutes, Federal Reserve Chair Jerome Powell sought to provide reassurance that any surge in price pressures won’t last.Elsewhere, oil rose after the dollar retreated. Bitcoin neared an all-time high before a listing by the largest U.S. cryptocurrency exchange.Some key events to watch this week:Banks and financial firms begin reporting first-quarter earnings, including JPMorgan Chase & Co., Citigroup Inc., Bank of America Corp., Morgan Stanley, Goldman Sachs Group Inc.U.S. officials and company executives are due to discuss the global shortage of computer chips on Monday.The U.S. releases inflation data Tuesday.Chinese trade data are scheduled for Tuesday.Economic Club of Washington hosts Fed Chair Jerome Powell for a moderated Q&A on Wednesday.U.S. Federal Reserve releases Beige Book on Wednesday.U.S. data including initial jobless claims, industrial production and retail sales come Thursday.China economic growth, industrial production and retail sales figures are on Friday.These are some of the main moves in financial markets: For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
New York, New York--(Newsfile Corp. - April 12, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Canoo Inc. ("Canoo") (NASDAQ: GOEV) between August 18, 2020 and March 29, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Central District of California. To get more information ...
New York, New York--(Newsfile Corp. - April 12, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of bluebird bio, Inc. (NASDAQ: BLUE) between May 11, 2020 and November 4, 2020, inclusive (the "Class Period") of the important April 13, 2021 lead plaintiff deadline.SO WHAT: If you purchased bluebird securities during the Class Period you may be entitled to compensation without payment of any out of pocket ...
The NHL trade deadline is 3 p.m. The Detroit Red Wings have already made multiple moves.
[225+ Pages Research Report] According to the recent research report; the global Active Pharmaceutical Ingredient Market in 2019 was approximately USD 177.6 Billion. The market is expected to surge at a CAGR of 5.5% and is anticipated to surpass USD 258.3 Billion by 2026. Top market players in the market are Abbvie Inc., Dr. Reddy’s Laboratories Ltd, Eli Lilly and Company, Cipla, Bristol Myers Squibb, Boehringer Ingelheim GmbH and others.New York, NY, April 12, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “Active Pharmaceutical Ingredient Market By Type (Innovative APIs, and Generic APIS), By Manufacturer (Captive Manufacturers, and Merchant Manufacturers), By Type of Synthesis (Synthetic, and Biotech), By Drug Type (Prescription Drugs, and Over-the-counter Drugs), and By Therapeutic Application (Communicable Diseases, Oncology, Diabetes, Cardiovascular Disease, Pain Management, Respiratory Diseases, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026”. “According to the research report, the global Active Pharmaceutical Ingredient Market was estimated at USD 177.6 Billion in 2019 and is expected to reach USD 258.3 Billion by 2026. The global Active Pharmaceutical Ingredient Market is expected to grow at a compound annual growth rate (CAGR) of 5.5% from 2019 to 2026”. Active Pharmaceutical Ingredient Market: Overview and Definition APIs are synthetic and organically dynamic components of drugs that have a direct effect on disease cure, moderation, care, and counteraction. Because of the increased use of medications and biologics in the treatment of diseases, the global API market has grown dramatically in recent decades. The growing use of value models in API manufacturing, such as Good Manufacturing Practices (GMP) and current GMP (cGMP), as well as the global acceptance of International Conference on Harmonization (ICH) laws, has strengthened security guidelines. On the other hand, the API industry is facing challenges such as reducing development time, lowering development costs, improving process structure, and meeting quality requirements without sacrificing profit. Request to Download Your Free Sample Report of Active Pharmaceutical Ingredient Market @ https://www.fnfresearch.com/sample/active-pharmaceutical-ingredient-market (The free sample of this report is readily available on request). Our Free Sample Report Includes: 2020 Updated Report Introduction, Overview, and In-depth industry analysisCOVID-19 Pandemic Outbreak Impact Analysis Included190+ Pages Research Report (Inclusion of Updated Research)Provide Chapter-wise guidance on Request2020 Updated Regional Analysis with Graphical Representation of Size, Share & TrendsIncludes Updated List of table & figuresUpdated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue AnalysisFacts and Factors research methodology (Note: The sample of this report is updated with COVID-19 impact analysis before delivery) Key Questions Answered in this Report 1) What were the pre and post-business impacts of COVID-19 on the Active Pharmaceutical Ingredient Market? 2) What is the market size, share of the Active Pharmaceutical Ingredient Market? 3) Who are the top market players in Active Pharmaceutical Ingredient Market? 4) What will be the future market of the Active Pharmaceutical Ingredient Market? Key Offerings: Market Size & Forecast by Revenue | 2020−2026Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunitiesMarket Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geographyCompetitive Landscape – Top key vendors and other prominent vendors Inquire more about this report before purchase @ https://www.fnfresearch.com/inquiry/active-pharmaceutical-ingredient-market (You may enquire a report quote OR available discount offers to our sales team before purchase.) Active Pharmaceutical Ingredient Market: Industry Major Market Players CiplaBristol Myers SquibbBoehringer Ingelheim GmbHBASF SEAurobindo PharmaAlbemarle CorporationAbbvie Inc.Dr. Reddy’s Laboratories LtdEli Lilly and CompanyViatris IncTeva Pharmaceutical Industries LtdSun Pharmaceutical Industries LtdSanofiPfizer Inc.Novartis AGMylan NVMerck & Co.Lupin Ltd To know an additional revised 2020 list of market players, request a sample report: https://www.fnfresearch.com/sample/active-pharmaceutical-ingredient-market Active Pharmaceutical Ingredient Market: Market Dynamics Advances in active pharmaceutical ingredient (API) manufacturing, as well as the increasing prevalence of chronic diseases like cardiovascular disease and cancer, are both contributing to the rise. Government policies that encourage API demand, as well as shifts in geopolitical circumstances, are propelling the market forward. The API market is experiencing significant changes as a result of COVID-19's supply chain disruption. Due to geopolitical circumstances and a desire to minimize reliance on China for API goods, countries such as India are being favored over China for API export. Furthermore, several governments have devised policies and provided incentives to encourage the development of goods. Increased R&D programs for novel drug production, as well as favorable government legislation, are credited with the growth of the innovative APIs market. Many products are now in the pipeline as a result of extensive research in this area and are expected to be launched during the forecast era. The competition is expected to be driven by new entrants. Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/active-pharmaceutical-ingredient-market In 2020, the synthetic API segment had the highest revenue share of 69.97 % this is due to the increased availability of raw materials and the ease with which these molecules can be synthesized. Many synthetic molecules are also expected to become off-patent in the coming years, boosting development. Over the forecast era, the biotech segment is projected to develop at the fastest CAGR of 7.2%. Factors such as rising demand for biopharmaceuticals and higher molecule efficiency are propelling this segment forward. Furthermore, high investments in the biotechnology and biopharmaceutical sectors can be attributed to the biotech segment's growth. This opens the door to the development of new molecules that help in the treatment of diseases like cancer. Biotech-related API's high revenue makes the industry highly lucrative, attracting major players. For example, Clinigen, Inc.'s Proleukin (aldesleukin) is a biologic therapy for metastatic renal cell carcinoma. Global Active Pharmaceutical Ingredient Market: Growth Factor The growing activity for research and development on drug production increased popularity of generic products, and the use of biopharmaceuticals, are the key factors driving the growth of the global active pharmaceutical industry. The unfavorable policies of price regulation for drugs in different countries and high production costs are, however, likely to hamper demand growth. The growing prevalence of chronic diseases would raise the demand for medicines, which is projected to accelerate the market growth of active pharmaceutical ingredients in the immediate future. The world's leading cause of death was cardiovascular diseases, estimating about 17.9 million lives a year, according to the WHO. Around 5.8 million people in the U.S. were reported to suffer from Alzheimer's in 2018 by the Alzheimer's Association. The illness is the sixth most common cause of death for people over 65 years of age in the United States. The population of baby booms is estimated to reach 14 million and to intensify in the projected timeframe, approaching the age of about 65. By 2050, every 33 seconds a new case of this disease could arise. Request Customized Copy of Report @ https://www.fnfresearch.com/customization/active-pharmaceutical-ingredient-market (We customize your report according to your research need. Ask our sales team for report customization.) North America is projected to Dominate Global Active Pharmaceutical Ingredients Market Growth North America had the highest market share of 41.5 percent in 2019 and is projected to hold that position during the forecast period. This can be due to the increasing epidemiology of cancer and other lifestyle-related diseases, which encourages R&D and thus boosts business growth. During the forecast era, Asia Pacific is expected to have the highest CAGR of 7.4%. The presence of economies like China and India, which the world relies on for low-cost API production, is a benefit for the region. The market is expected to rise due to rising healthcare expenditure in the region. Browse the full “Active Pharmaceutical Ingredient Market By Type (Innovative APIs, and Generic APIS), By Manufacturer (Captive Manufacturers, and Merchant Manufacturers), By Type of Synthesis (Synthetic, and Biotech), By Drug Type (Prescription Drugs, and Over-the-counter Drugs), and By Therapeutic Application (Communicable Diseases, Oncology, Diabetes, Cardiovascular Disease, Pain Management, Respiratory Diseases, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026” report at https://www.fnfresearch.com/active-pharmaceutical-ingredient-market The global active pharmaceutical ingredients market is segmented as follows: By Type: Innovative APIsGeneric APIs By Manufacturer: Captive ManufacturersMerchant Manufacturers By Type of Synthesis: SyntheticBiotech By Drug Type: Prescription DrugsOver-the-counter Drugs By Therapeutic Application: Communicable DiseasesOncology, DiabetesCardiovascular DiseasePain managementRespiratory DiseasesOthers For media/report purchase inquiry, email us at firstname.lastname@example.org Related Reports: Pyridine Market: https://www.fnfresearch.com/pyridine-market-by-product-type-pyridine-n-oxide-1234 Erectile Dysfunction Drugs Market: https://www.fnfresearch.com/erectile-dysfunction-drugs-market Antimalarial Drugs Market: https://www.fnfresearch.com/antimalarial-drugs-market-by-drug-class-quinine-chloroquine-1128 Diarrhea Drug Market: https://www.fnfresearch.com/diarrhea-drug-market-product-type-adult-diarrhea-drug-857 Pharmacokinetics Services Market: https://www.fnfresearch.com/pharmacokinetics-services-market-by-drug-type-large-molecules-979 About Facts & Factors (FnF Research): Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business. Follow Us LinkedIn: https://www.linkedin.com/company/fnfresearch Follow Us Twitter: https://twitter.com/fnfresearch Contact Us: Facts & Factors USA: +1-347-989-3985 Email: email@example.com Web: https://www.fnfresearch.com Blog: http://fnfnewsblog.com
Ryan, a leading global tax services and software provider, has been named to the 2021 FORTUNE 100 Best Companies to Work For® list, ranking 66. This year’s recognition marks the fourth consecutive year Ryan has been selected as one of the 100 premier workplaces in the United States.
JanSport today introduced Surplus Ski n' Hike, the brand's first backpack collection made with excess factory materials that may have otherwise ended up in landfills. The launch marks another milestone in the brand's mission to become a leader in sustainable backpack design and manufacturing. The new collection will be available beginning Monday, April 12, 2021 on jansport.com/surplus.
Today G/O Media, a leading digital publisher, announced the appointment of sales and media executive David Spiegel to the role of Chief Revenue Officer. In this role, Mr. Spiegel will lead direct, branded, and programmatic revenue efforts across G/O Media's portfolio of brands, which include eleven category-leading digital sites. This role is effective April 19, 2021.
Leviton, the nation's leading provider of electrical wiring devices, today announced a new partnership with the electrical training ALLIANCE (etA), the nation's largest electrical training organization. With the goal of developing the best trained and most technically advanced electrical workforce in the world, the five-year agreement will bring funding, training kits, instruction and technical expertise through traditional and digital training curriculum platforms.
Prince Harry has arrived safely in the UK for Prince Philip’s funeral and has released a touching tribute to his late grandfather. Below is the Duke of Sussex’s statement in full, released through his Archewell Foundation: “My grandfather was a man of service, honour and great humour. He was authentically himself, with a seriously sharp […]
"Top 10 Celebrity Home Tours"
Energy Harbor Corp. announced today its Unit 1 at the Beaver Valley Nuclear Power Station in Shippingport, Pennsylvania, was taken offline at 12:01 a.m. on Sunday, April 11, for scheduled refueling and preventative maintenance.
Blackbaud (NASDAQ: BLKB), the world's leading cloud software company powering social good, is pleased to announce that its Chief Marketing Officer Catherine Cook LaCour has been named one of the 2021 Top 50 Most Powerful Women in Technology by DiversityFirst™ and the National Diversity Council. The award honors female leaders who have become champions for diversity in the technology industry, as well as inspirations in their communities.
Terumo is proud to announce the launch of its Global Therapeutic Interventional Oncology team as of April 1st, 2021. This reflects Terumo's aspiration to be a Global leader in the field of Interventional Oncology by focusing on improving patient's quality of life and survival.
The Dow Jones Industrial Average remain near record highs at the end of March, as the current stock market rally continues. The best Dow Jones stocks to buy and watch in April 2021 are Apple, Boeing, Disney and Microsoft.
Footfall doubles as queues form outside branches of Primark, JD Sports and TK Maxx.
DLA Piper represented Orbis Operations in its recent acquisition by McNally Capital. Orbis Operations is a leading provider of intelligence and national security advisory services, software engineering and cyber services, and situational awareness training to the United States government and its allies, as well as select commercial clients.
First project to use advanced analytics to explore identity shifts in alcohol addiction London, United Kingdom--(Newsfile Corp. - April 12, 2021) - Awakn Life Sciences Inc., a clinical-biotech company researching, developing, and delivering psychedelic medicine to treat addiction and other mental health conditions, today launched 'Awakn Digital', a new unit focused on using advanced analytics to improve the effectiveness of Psychedelic-Assisted Psychotherapy in treating Addiction. Awakn deepened its partnership with the University of Exeter ...
Eight years ago this month Jerome Powell, still in his rookie year as a Federal Reserve governor, surveyed the U.S. job market and declared it was good enough for the central bank to reduce the support for the economy it had rolled out to fight the 2007 to 2009 financial crisis. The unemployment rate had just hit a post-crisis low of roughly 7.5%. "We've achieved substantial progress towards our economic objectives," Powell told his colleagues according to transcripts of that April 30-May 1, 2013, Federal Open Market Committee meeting.
Former Connecticut men's basketball coach Kevin Ollie will be head coach for Overtime Elite, a new basketball league for top high school players.